Immunogenic cell death (ICD) is a type of cancer cell death triggered by certain
chemotherapeutic drugs, oncolytic viruses, physicochemical therapies, photodynamic …

In the tumour microenvironment (TME), immunogenic cell death (ICD) plays a major role in
stimulating the dysfunctional antitumour immune system. Chronic exposure of damage …

Immunogenic cell death (ICD), which is triggered by exposure of tumor cells to a limited
range of anticancer drugs, radiotherapy, and photodynamic therapy, represents a recent …

Mammalian cells responding to specific perturbations of homeostasis can undergo a
regulated variant of cell death that elicits adaptive immune responses. As immunogenic cell …

Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …

Immunogenic cell death (ICD) is a modality of regulated cell death that is sufficient to
promote an adaptive immune response against antigens of the dying cell in an …

Immunotherapy is a promising treatment modality that acts by selectively harnessing the
host immune defenses against cancer. An effective immune response is often needed to …

The concept of immunogenic cancer cell death (ICD), as originally observed during the
treatment with several chemotherapeutics or ionizing irradiation, has revolutionized the view …

Apoptotic cell death generally characterized by a morphologically homogenous entity has
been considered to be essentially non-immunogenic. However, apoptotic cancer cell death …

Cancer immunosurvelliance usually leads to formation of cancer cells that have been
“immunoedited” to resist anti‐tumor immunity. One of the consequences of immunoediting …